Artemether-Lumefantrine Treatment Selects Plasmodium falciparum Multidrug Resistance 1 ( pfmdr1 ) Increased Copy Number Among African Malaria Infections
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiaf155 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Claudia Fançony und 17 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigação em Saúde de Angola, Instituto Nacional de Investigação em Saúde, Caxito, Angola. Hauptthemen laut MEDLINE: Plasmodium falciparum, Malaria, Falciparum, Ethanolamines, Antimalarials. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Agha Kan Development, Fundação para a Ciência e Tecnologia, Portugal.
Abstract (Originalsprache)
Background
Decreased efficacy of artemether-lumefantrine, the globally most used antimalarial, has recently emerged in Africa.
Methods
An efficacy trial was carried out based on directly observed artemether-lumefantrine therapy at Bengo, Northern Angola. One-hundred Plasmodium falciparum uncomplicated malaria patients (2–10 years old) were enrolled, hospitalized for the treatment period, and followed up for 42 days. Polymerase chain reaction (PCR) correction was performed with pfmsp1/2 plus glurp, with analysis considering 2 or 3 coincident markers. Infections were tested by quantitative PCR (qPCR) for pfmdr1 copy number (pfmdr1×N), a potential P. falciparum marker of lumefantrine resistance previously identified in the region. In vitro clone mixtures were built and used to determine the relation between qPCR copy number scores and actual intrainfection quantitative fractions of pfmdr1×N.
Results
We observed a significant posttreatment selection of gene amplification, suggesting a role in the parasite in vivo response to this drug. pfmdr1×2 qPCR scores of 1.3, 1.4, and 1.5 were determined to correspond to 15%, 25%, and 35% intrainfection rates. Patients carrying infections with a score ≥1.4 at baseline were linked to decreased artemether-lumefantrine day 42 efficacy (79% vs 97% single-copy pfmdr1). All infections were pfmdr1 N86 carriers and no pfk13 mutations were found.
Conclusions
Our study suggests pfmdr1×N as a marker of P. falciparum in vivo response to lumefantrine in Africa, while indicating patients carrying infections with a pretreatment pfmdr1×N score ≥1.4 before treatment are a group experiencing decreased artemether-lumefantrine performance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Investigação em Saúde de Angola, Instituto Nacional de Investigação em Saúde, Caxito, Angola.
- Instituto Superior Técnico Militar, Luanda, Angola.
- Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
- Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
- The Art of Discovery, Derio, Basque Country, Spain.
- Faculdade de Medicina, Universidade Agostinho Neto, Luanda, Angola.
ORCID-Profile: Claudia Fançony, Elsa Fortes-Gabriel, Ioanna Broumou, Edite V N Rosario, Tais N de Sousa, José Pedro Gil
Förderung
- Agha Kan Development
- Fundação para a Ciência e Tecnologia
- Portugal
- Fundação Calouste Gulbenkian
- Swedish Research Council
- Vetenskaprådet
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- FCT
Zitieren
APA
Fançony, C., Fortes-Gabriel, E., Zage, F., Alexiou, E., Broumou, I., Pernaute-Lau, L., Panzo, J., António, E. J., Cristovão, M. S., Domingos, J. M., Sassoma, E., Kuatoko, F., Rosario, E. V. N., Martins, A., Färnert, A., Bernardino, L., de Sousa, T. N., & Gil, J. P. (2025). Artemether-Lumefantrine Treatment Selects Plasmodium falciparum Multidrug Resistance 1 ( pfmdr1 ) Increased Copy Number Among African Malaria Infections. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf155
Vancouver
Fançony C, Fortes-Gabriel E, Zage F, Alexiou E, Broumou I, Pernaute-Lau L, et al. Artemether-Lumefantrine Treatment Selects Plasmodium falciparum Multidrug Resistance 1 ( pfmdr1 ) Increased Copy Number Among African Malaria Infections. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf155
BibTeX
@article{Fanony2025,
author = {Fançony, Claudia and Fortes-Gabriel, Elsa and Zage, Félix and Alexiou, Evangelia and Broumou, Ioanna and Pernaute-Lau, Leyre and Panzo, Jorge and António, Esperança J and Cristovão, Mario S and Domingos, José M and Sassoma, Estevão and Kuatoko, Fernando and Rosario, Edite V N and Martins, António and Färnert, Anna and Bernardino, Luis and de Sousa, Tais N and Gil, José Pedro},
title = {Artemether-Lumefantrine Treatment Selects Plasmodium falciparum Multidrug Resistance 1 ( pfmdr1 ) Increased Copy Number Among African Malaria Infections},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiaf155}
}
EUVIMED